In addition to the previously recalled lots of heparin sodium injection 1000 units/mL 10mL and 30mL multi- dose vials, Baxter's recall will now include the remaining lots of those products and heparin sodium injection 5000 units/mL 10mL multi-dose vials, heparin sodium injection 10,000 units/mL 4mL multi-dose vials, heparin sodium injection 1000 USP units/mL, 5000 USP units/mL, and 10,000 USP units/mL single-dose vials, and all HEP-LOCK
U/P, 10 USP units/mL and 100 USP units/mL vials, both preserved and preservative-free.
The patient given the wrong medication could be given an antidote; the occluded hep-lock
could be replaced; the patient who are could be rescheduled for another day, or have their stomach contents drained before surgery; charting could be corrected before other mistakes are made; consent can be obtained or the transfusion could be stopped; additional labs can be drawn and precautions can be taken to avoid over-dose and proper monitoring of the patient may be ordered if the nurse involved would just admit to making a mistake.
After receiving additional reports of similar adverse reactions from other lots of their Heparin Sodium Injection Products, Baxter recalled their remaining multi-dose and single-dose vials, as well as HEP-LOCK
Heparin Flush Products.
to recall single-dose and mul-tidose heparin vials and HEP-LOCK
heparin flush products on Feb.